Plaza de la Revolución, Cuba

Camilo Rodríguez Rodríguez


Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Approaches in Cancer Treatment: The Invention of Camilo Rodríguez Rodríguez**

Introduction

Camilo Rodríguez Rodríguez, based in Plaza de la Revolución, CU, is an innovative inventor known for his pioneering work in the field of pharmaceutical compositions. With a focus on cancer treatment, he has developed a significant patent that showcases the potential of immunomodulatory therapies.

Latest Patents

Rodríguez holds one patent titled "Ganglioside GM3-containing nanoparticles as immunomodulators." This groundbreaking invention describes a pharmaceutical composition whose active ingredient consists of conjugates of membrane vesicles and the GM3 ganglioside in a conjugation ratio exceeding that of proteins. The characteristics of size, surface charge, and nano-particulate morphology give it advantageous immunomodulatory properties. This innovation notably induces a reduction in myeloid-derived suppressor cells, positively impacting lymphocyte responses and improving survival rates in patients with tumors. The patent also discloses applications for treating various cancers, especially those with elevated myeloid-derived suppressor cells (MDSCs), alongside methods for selecting suitable patients for this treatment.

Career Highlights

Camilo Rodríguez Rodríguez works at the Centro de Inmunología Molecular, where he actively contributes to advancing cancer treatment through innovative research and development. His dedication to improving patient outcomes showcases his commitment to the field of immunology and pharmaceutical sciences.

Collaborations

Throughout his career, Rodríguez has collaborated with esteemed colleagues, including Circe Mesa Pardillo and Liliana Oliver Ríos. These partnerships foster a dynamic exchange of ideas and expertise, enhancing the research environment at the Centro de Inmunología Molecular.

Conclusion

Camilo Rodríguez Rodríguez stands out as a notable inventor in the realm of cancer therapeutics. His patent on GM3-containing nanoparticles demonstrates his innovative approach to immunomodulation, offering hopeful prospects for patients battling cancer. His work at the Centro de Inmunología Molecular and collaborations with fellow researchers underscore the collective effort needed in the scientific community to advance healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…